Screener
GoodRx Holdings, Inc. GDRX Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from GoodRx Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001809519-26-000152
FAQ
- What is GoodRx Holdings, Inc.'s net debt / EBITDA?
- GoodRx Holdings, Inc. (GDRX) reported net debt / EBITDA of 1.5× in Q2 2026.
- How has GoodRx Holdings, Inc.'s net debt / EBITDA changed year-over-year?
- GoodRx Holdings, Inc.'s net debt / EBITDA decreased by 7.4% year-over-year, from 1.6× to 1.5×.
- What is the long-term trend for GoodRx Holdings, Inc.'s net debt / EBITDA?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s net debt / EBITDA has grown at a -24.4% compound annual growth rate (CAGR), from -5× to 1.6×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about GoodRx Holdings, Inc.'s net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude